Zupancic, CEO of Baltimore fitness company, died after years of battling ovarian cancer, according to a social media post by ...

Research has shed light on how a new type of antibody treatment reactivates patients' immune cells to fight ovarian cancer.

Antibody-drug conjugates and their development remains a central theme in ongoing research within the realm of ovarian cancer ...

A woman's story of literal strength shows how ovarian cancer can be missed—and the lighthearted recovery milestone every care ...

Patients with advanced epithelial ovarian cancer who were non-Hispanic Black, older, had lower household income, resided in ...

Chemotherapy regimens chosen by the ChemoID assay dramatically increased ORR in patients with platinum-resistant ovarian ...

As the university advances plans for a new, state-of-the-art Cancer Research Building, leaders say the facility will pave the ...

To optimize treatment outcomes for patients whose late-stage cancer shows resistance to the standard treatment, Sarasota Memorial Research Institute will participate in testing an experimental ...

Discover the Witchery White Shirt Campaign 2025 in collaboration with Viktoria & Woods founder, Margie Woods, for ovarian ...

University of Kentucky Markey Cancer Center researchers presented promising results from an early-stage clinical trial ...

In fact, a study published in the Journal of Royal Society of Medicine revealed that if lung cancer in non-smokers was ...

Verastem, Inc.'s priority PDUFA date for avutometinib + defactinib in LGSOC set for June 2025; explore future data updates.